Kim, C. G., Hong, M. H., Kim, J., Hong, M., Shim, H. S., Han, M., Kim, E. Y., Park, B. J., Kim, H. E., Yang, Y. H., Hong, T. H., Lee, C. Y., Kim, H. R. (2025). A window of opportunity study for preoperative brigatinib in resectable anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC): WILDERNESS trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8040